Money for peanuts in WA bid to cut allergy rates
Medically supervised 'peanut clinics' to test benefits of early exposure
400 infant participants sought for trial
Part of $2.2 million health research program to improve patient outcomes
Potential healthcare savings of more than $2.4 million a year
Perth doctors will trial safe, medically supervised 'peanut clinics' in an attempt to reduce Western Australia's rising rates of peanut allergy.
Health Minister John Day said allergy researchers were hoping to test 400 infants for the potential benefits of early exposure to peanut products.
"Peanut allergy is the most common cause of severe food allergy and is extremely distressing and potentially deadly," Mr Day said.
"It is thought to affect about three per cent of children and, with rates of peanut allergy rising steadily over the past 20 years, we hope this project will help turn the tide."
Early exposure to peanuts is known to reduce the risk of allergy development in later childhood, with current guidelines recommending that children at high risk be exposed from as early as four months of age.
"Unfortunately, parental apprehension at introducing peanuts is delaying exposure for many children, with only 20 per cent at high risk of developing peanut allergy being exposed within the optimal timeframe," the Minister said.
Results from the safe 'peanut clinics' will allow researchers to compare the incidence of allergy among groups of children exposed early with those exposed later.
"If the intervention proves effective, 'peanut clinics' could be introduced across a variety of settings including GP practices and child health clinics," Mr Day said.
"This would reduce trauma, improve outcomes for young families and deliver estimated healthcare savings of more than $2.4 million a year.
"The trial is being funded as part of the latest $2.2 million round of the Liberal National Government's Research Translation Project (RTP) grants which aim to increase health system efficiency."
The peanut allergy project is being led by Dr Michael O'Sullivan, a consultant immunologist with Princess Margaret and Fiona Stanley hospitals, and is expected to start in March 2017.
Fact File
Risk factors for infants developing peanut allergy include eczema, egg allergy and a family history of allergies
Projects funded under the RTP program must be completed within two years
For more information, visit http://www.health.wa.gov.au
Minister's office - 6552 6200
| Coordinating Principal Investigator (CPI) | CPI Institution | Round 10 Research Translation Projects |
| Benhur Amanuel | PathWest | Clinical implementation of personalised medicine for five high-priority WA cancers |
| Camile Farah | The University of Western Australia | Image-guided oncological surgery improves patient outcomes in management of head and neck cancer |
| Graham Hillis | Royal Perth Hospital | The RoyAl Perth evidence-based accelerated chest pain pathway (RAPID) Study |
| Edward Litton | Fiona Stanley Hospital | Restoration Of the microbiome in CrITical illness: The ROCIT Study |
| Jenny McCloskey | King Edward Memorial Hospital | Proof of concept cervical human papillomavirus treatment trial |
| Michael O'Sullivan | Child and Adolescent Health Service | The Promoting Introduction to Prevent Peanut Allergy (PIPPA) project |
| Thomas Snelling | Telethon Kids Institute | Evaluation of PLATINUM C: PLATform IN the Use of Medicines to treat chronic hepatitis C |
| Teresa Williams | Curtin University | A randomised controlled trial of Continuous Positive Airway Pressure (CPAP) for the treatment of severe respiratory distress by ambulance paramedics in the pre-hospital setting |
| Dao-Yi Yu | Lions Eye Institute | A novel approach to significantly improve clinical management of glaucoma |
| Mel Ziman | Edith Cowan University | A blood-based 'liquid biopsy' to improve healthcare for metastatic melanoma patients |